KROSNasdaq GM

Keros Therapeutics, Inc.

11.68+8.35%1d

Data as of Aug 25, 2026 · end-of-day snapshot

Volume signal tierC
Alert levelBaseline

Tier and alert level are a summary. Unlock KROS to see the full accumulation read: relative-volume ratios, z-scores, money-flow and float turnover behind this signal.

+10.08%, upReturn · 1w
+14.40%, upReturn · 1m
+3.27%, upReturn · 3m
−20.87%, downReturn · 1y
−48.20%, well below its 52-week highvs 52-week high
Technicals

Technical readings

The latest end-of-day reading across momentum, trend and volatility signals, included free on every stock page.

Automated read

Price is trading below its key moving averages: the mid-term picture reads as a downtrend. RSI is currently 61.

RSI (14)60.94, favorable readingUpper-neutral
MACD / signal0.14 / 0.04, favorable readingAbove signal line
SMA 5010.71, favorable readingPrice above
SMA 20013.89, caution readingPrice below
EMA 2010.77, favorable readingPrice above
ADX (14)24.20Firming
+DI / −DI27.82 / 12.01, favorable reading+DI leading
ATR (14)0.585.0% of price — typical daily swing
Stochastic %K98.28, flagged readingOverbought zone
Bollinger bands (20)9.67 – 11.56Above upper band: stretched
ROC (10)9.77, favorable readingPositive over 10 sessions
Trend / momentum impulseBoth rising, favorable impulse readingTrend and momentum agree

Readings as of Aug 25, 2026 · end-of-day snapshot

Full analysis

What unlocking KROS reveals

Sample preview: figures are illustrative.

Company & theme write-up

Signal history

AI narrative

Catalysts & risks

Accumulation read

Unlock KROS: full analysis
Free weekly sample report

Get a full sample stock analysis in your inbox every week, no card, just the same read you see here on one hand-picked ticker.

Need the raw data?Get KROS + ~22,000 stocks as a clean CSV: every column, ready to load into a spreadsheet or notebook.
Build a dataset
$9.90one-time Unlock KROS